146 results
Page 3 of 8
8-K
bmcu6
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-1.1
7m8p7 veo
20 Aug 21
Entry into a Material Definitive Agreement
4:30pm
8-K
EX-10.1
b5sg0 p62zen
17 Jun 21
PROCESSA PHARMACEUTICALS ENTERS INTO A LICENSING AGREEMENT WITH OCUPHIRE PHARMA, INC., FOR the Development of RX-3117
11:35am
8-K
EX-10.1
59a322m3m71bzlg16rqv
18 Feb 21
Processa Pharmaceuticals Announces $10.2 Million Strategic Financing
10:08am
8-K
EX-1.1
8oiu9
6 Oct 20
Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
4:05pm